FrancophonIA/ELRC3.0 huggingface dataset:
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports)
Croatian: Učestalost nuspojava je određena sukladno sljedećim pravilima: - vrlo česte (više od 1 na 10 tretiranih životinja pokazuju nuspojave) - česte (više od 1 ali manje od 10 životinja na 100 tretiranih životinja) - manje česte (više od 1 ali manje od 10 životinja na 1.000 tretiranih životinja) - rijetke (više od 1 ali manje od 10 životinja na 10.000 tretiranih životinja)
English: It is efficacious against ticks (Ixodes spp., Dermacentor spp.
Croatian: Učinkovit je protiv krpelja (Ixodes spp., Dermacentor spp. i
English: Safety was demonstrated in breeding, pregnant and lactating animals treated with overdoses of up to 3 times the maximum recommended dose.
Croatian: Neškodljivost je dokazana u rasplodnih pasa, te kuja u laktaciji i graviditetu tretiranih s i do 3 x većim dozama od maksimalne preporučene doze.
English: Hypersensitivity reactions to the product have been reported in a small number of people.
Croatian: Kod manjeg broja ljudi uočljiva je reakcija preosjetljivosti na proizvod.
English: Intervet International B. V. Wim de Körverstraat 35 5831 AN Boxmeer The Netherlands
Croatian: Wim de Körverstraat 35 5831 AN Boxmeer Nizozemska
English: Strength and number of tablets to be administered
Croatian: Jačina i broj tableta za primjenu
English: Administer Bravecto chewable tablets at or around the time of feeding.
Croatian: Primijeniti Bravecto tablete za žvakanje u vrijeme hranjenja.
English: Strength and number of pipettes to be administered
Croatian: Jačina i broj pipeta za primjenu
English: for small cats 1.2 - 2.8 kg for medium-sized cats >2.8 - 6.25 kg for large cats >6.25 - 12.5 kg
Croatian: za male mačke 1,2 - 2,8 kg za srednje velike mačke >2,8 - 6,25 kg za velike mačke >6,25 - 12,5 kg
English: Keep the product in the original packaging until use in order to prevent children from getting access to the product.
Croatian: Čuvati proizvod u originalnom pakovanju do primjene radi sprečavanja doticaja djece sa proizvodom.
English: Do not use this veterinary medicinal product after the expiry date which is stated on the blister after EXP.
Croatian: Ne primjenjivati veterinarsko-medicinski proizvod nakon isteka roka valjanosti koji je naznačen na blisteru.
English: Intervet UK Limited Walton Manor, Walton, Milton Keynes, Buckinghamshire, MK7 7AJ United Kingdom
Croatian: Intervet UK Limited Walton Manor, Walton, Milton Keynes,
English: The safety of the veterinary medicinal product has not been established during pregnancy and lactation.
Croatian: Neškodljivost ovog veterinarsko-medicinskog proizvoda tijekom graviditeta i laktacije nije utvrđena.
English: Each chewable tablet contains:
Croatian: Svaka pipeta sadrži:
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Sachet
Croatian: OSNOVNI PODACI NAPISANI NA MALIM JEDINICAMA UNUTARNJIH PAKOVANJA
English: The product should not be administered at intervals shorter than 8 weeks as the safety at shorter intervals has not been tested.
Croatian: Proizvod ne treba primjenjivati u intervalima kraćim od 8 tjedana jer neškodljivost u kraćim intervalima nije ispitana.
English: In order to avoid contact, disposable protective gloves obtained with this product at the point of sale must be worn when handling and administering the product.
Croatian: Da bi izbjegli kontakt, treba nositi zaštitne rukavice prilikom rukovanja i primjene proizvoda , dostupne uz ovaj proizvod na mjestu prodaje.
English: If you notice any side effects, even those not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinary surgeon.
Croatian: Ako zamijetite nuspojave ili druge simptome koji nisu opisani u uputi o VMP ili mislite da je proizvod nedjelotvoran, molimo obavijestite veterinara.
English: There were no findings on reproductive performance and no findings of concern on offspring viability when fluralaner was administered orally to Beagle dogs at overdoses of up to 3 times the maximum recommended dose (up to 168 mg/kg bodyweight of fluralaner).
Croatian: Nije bilo nikakvog utjecaja na reproduktivne sposobnosti niti na održivost graviditeta kad je fluralaner bio peroralno primijenjen na biglovima u 3 x većoj dozi od maksimalne preporučene doze (do 168 mg/kg fluralanera/tjelesne težine).
English: The pipette should be held by the base or by the upper rigid portion below the cap in an upright position (tip up) for opening it.
Croatian: Prilikom otvaranja pipetu treba držati po sredini ili pri gornjem čvrstom dijelu ispod zatvarača u uspravnom položaju.
English: The sachets should only be opened immediateley prior to use.
Croatian: Vrećicu bi trebalo otvarati neposredno prije primjene.
English: The product contributes towards the control of environmental flea populations in areas to which treated cats have access.
Croatian: Proizvod pomaže kontroli populacije buha u okolini tretiranih mačaka.
English: Avoid the application of more than 1 ml of solution at any one spot as it could cause some of the solution to run or drip off the dog.
Croatian: Izbjegavati aplikaciju većeg sadržaja na jedno mjesto kako bi se izbjeglo curenje ili cijeđenje sa psa.
English: Bravecto should be administered in accordance with the following table (corresponding to a dose of 40 - 94 mg fluralaner/kg body weight):
Croatian: Bravecto treba primjenjivati u skladu sa sljedećom tablicom (odgovarajuća doza od 40 - 94 mg fluralanera/kg tjelesne težine unutar pojedine skupine):
English: Pregnancy, lactation and fertility: Can be used in breeding, pregnant and lactating dogs.
Croatian: Primjena tijekom graviditeta, laktacije ili nesenja Može se primjenjivati na rasplodne pse, te kuje u graviditetu i laktaciji.
English: EU/2/13/158/001 EU/2/13/158/002 EU/2/13/158/003 EU/2/13/158/004 EU/2/13/158/005 EU/2/13/158/006 EU/2/13/158/007 EU/2/13/158/008 EU/2/13/158/009 EU/2/13/158/010 EU/2/13/158/011 EU/2/13/158/012 EU/2/13/158/013
Croatian: EU/2/13/158/001 EU/2/13/158/002 EU/2/13/158/003 EU/2/13/158/004 EU/2/13/158/005 EU/2/13/158/006 EU/2/13/158/007 EU/2/13/158/008 EU/2/13/158/009 EU/2/13/158/010
English: Place the pipette tip on the base of the skull of the cat.
Croatian: Stavite vrh pipete na stražnji dio glave mačke (početak vrata).
English: Bravecto 112.5 mg (2-4.5 kg) Bravecto 250 mg (>4.5 -10 kg) Bravecto 500 mg (>10 -20 kg) Bravecto 1,000 mg (>20 -40 kg) Bravecto 1,400 mg (>40 -56 kg) fluralaner
Croatian: Bravecto 112,5 mg (2-4,5 kg) Bravecto 250 mg (>4,5 -10 kg) Bravecto 500 mg (>10-20 kg) Bravecto 1000 mg (>20-40 kg) Bravecto 1400 mg (>40-56 kg)
English: Mild and transient gastrointestinal effects such as diarrhoea, vomiting, inappetence, and drooling were commonly observed in clinical trials (1.6% of treated dogs).
Croatian: Prolazni gastrointestinalni simptomi poput proljeva, povraćanja, inapetencije i slinjenja, često su uočeni u kliničkim istraživanjima (1,6 % tretiranih pasa).
English: Shelf life of the veterinary medicinal product as packaged for sale: Bravecto 112.5 mg spot-on solution: 2 years Bravecto 250 mg / 500 mg spot-on solution: 3 years
Croatian: Rok valjanosti veterinarsko-medicinskog proizvoda kad je zapakiran za prodaju: Bravecto 112,5 mg otopina za nakapavanje: 2 godine.
English: Avoid contact with skin, mouth and/or eye. Do not contact the application site until it is no longer noticeable.
Croatian: Izbjegavati kontakt s kožom, ustima i/ili očima.
English: EU/2/13/158/001-015
Croatian: EU/2/13/158/016-017 112,5 mg
English: The product contributes towards the control of environmental flea populations in areas to which treated dogs have access.
Croatian: Proizvod pomaže kontroli populacije buha u okolini tretiranog psa.
English: Unchanged fluralaner is excreted in feces and to a very low extent in urine.
Croatian: Glavni put eliminacije je izlučivanje nepromijenjenog fluralanera u fecesu a manji dio u urinu.
English: During clinical field testing, no interactions between Bravecto chewable tablets for dogs and routinely used veterinary medicinal products were observed.
Croatian: Tijekom terenskih ispitivanja, nisu primijećene interakcije između Bravecto tableta za žvakanje za pse i rutinski korištenih veterinarsko medicinskih proizvoda.
English: Do not use in case of hypersensitivity to the active substance or to any of the excipients.
Croatian: Ne primjenjivati u slučaju preosjetljivosti na djelatnu tvari ili na bilo koju od pomoćnih tvari.
English: For cats above 12.5 kg body weight, use a combination of two pipettes that most closely matches the body weight.
Croatian: Za mačke iznad 12,5 kg tjelesne težine primjenjivati kombinaciju od 2 pipete koje najviše odgovaraju tjelesnoj težini.
English: In the absence of available data, this veterinary medicinal product should not be used on kitten less than 11 weeks old and /or cats weighing less than 1.2 kg.
Croatian: U nedostatku dostupnih podataka, ovaj veterinarsko-medicinski proizvod ne upotrebljavati na mačićima do 11 tjedana starosti i/ili mačkama ispod 1,2 kg tjelesne mase.
English: Bravecto should be administered in accordance with the following table (corresponding to a dose of 25-56 mg fluralaner/kg bodyweight within one weight band):
Croatian: Bravecto treba primjenjivati u skladu sa sljedećom tablicom (odgovarajuća doza od 25-56 mg fluralanera/kg tjelesne težine unutar pojedine skupine):
English: Skin rashes tingling or numbness have been reported in a small number of individuals after skin contact.
Croatian: Poslije dodira s kožom kod manjeg broja ljudi prijavljene reakcije su bile osip po koži ili utrnulost.
English: Spot-on solution:
Croatian: Način primjene:
English: EU/2/13/158/016 (112.5 mg, 1 pipette) EU/2/13/158/017 (112.5 mg, 2 pipettes) EU/2/13/158/020 (250 mg, 1 pipette) EU/2/13/158/021 (250 mg, 2 pipettes) EU/2/13/158/024 (500 mg, 1 pipette) EU/2/13/158/025 (500 mg, 2 pipettes) EU/2/13/158/028 (1,000 mg, 1 pipette) EU/2/13/158/029 (1,000 mg, 2 pipettes) EU/2/13/158/030 (1,400 mg, 1 pipette) EU/2/13/158/031 (1,400 mg, 2 pipettes)
Croatian: EU/2/13/158/016 ( 112,5 mg, 1 pipeta) EU/2/13/158/017 ( 112,5 mg, 2 pipete) EU/2/13/158/020 ( 250 mg, 1 pipeta) EU/2/13/158/021 ( 250 mg, 2 pipete) EU/2/13/158/024 ( 500 mg, 1 pipeta) EU/2/13/158/025 ( 500 mg, 2 pipete) EU/2/13/158/028 ( 1000 mg, 1 pipeta) EU/2/13/158/029 ( 1000 mg, 2 pipete) EU/2/13/158/030 ( 1400 mg, 1 pipeta) EU/2/13/158/031 ( 1400 mg, 2 pipeta)
English: The twist-and-use cap should be rotated clockwise or counter clockwise one full turn.
Croatian: Zatvarač treba okrenuti u smjeru kazaljke na satu ili obrnuto cijeli krug.
English: Bravecto chewable tablets
Croatian: Bravecto otopina za nakapavanje
English: Can be used in breeding, pregnant and lactating dogs.
Croatian: Može se primjenjivati kod uzgojnih pasa te kuja u graviditetu i laktaciji.
English: The onset of efficacy is within 12 hours for fleas (C. felis) and within 48 hours for ticks (I. ricinus).
Croatian: Početak djelovanja je unutar 12 sati za buhe (C. felis) i 48 sati za krpelje (I. ricinus).
English: Pork liver flavour Sucrose
Croatian: Aroma svinjske jetre Saharoza
English: Pregnancy, lactation and fertility:
Croatian: Primjena tijekom graviditeta, laktacije ili nesenja
English: The onset of efficacy is within 8 hours for fleas (C. felis) and 12 hours for ticks (I. ricinus).
Croatian: Početak djelovanja je unutar 8 sati za buhe (C. felis) i 12 sati za krpelje (I. ricinus).
English: EU/2/13/158/018 (112.5 mg, 1 pipette) EU/2/13/158/019 (112.5 mg, 2 pipettes) EU/2/13/158/022 (250 mg, 1 pipette) EU/2/13/158/023 (250 mg, 2 pipettes) EU/2/13/158/026 (500 mg, 1 pipette) EU/2/13/158/027 (500 mg, 2 pipettes)
Croatian: EU/2/13/158/018 (112,5 mg, 1 pipeta) EU/2/13/158/019 (112,5 mg, 2 pipete) EU/2/13/158/022 ( 250 mg, 1 pipeta) EU/2/13/158/023 (250 mg, 2 pipete) EU/2/13/158/026 ( 500 mg, 1 pipeta) EU/2/13/158/027 ( 500 mg, 2 pipete)
English: The safety of the veterinary medicinal product in breeding, pregnant and lactating dogs has been demonstrated.
Croatian: Neškodljivost primjene ovog veterinarsko medicinskog proizvoda dokazana je kod uzgojnih pasa te kuja u graviditetu i laktaciji.
English: No adverse reactions were observed following topical administration to kitten aged 11-13 weeks and weighing 1.2-1.5 kg treated with overdoses of up to 5 times the maximum recommended dose (93 mg, 279 mg and 465 mg fluralaner/kg body weight) on three occasions at shorter intervals than recommended (8-week intervals).
Croatian: Neškodljivost je dokazana kod mačića starosti 11 - 13 tjedana i težine 1,2 - 1,5 kg tretiranih trokratno s 5 x većim dozama od maksimalno preporučene doze (93 mg, 279 mg i 465 mg fluralanera/kg tjelesne težine) i u kraćim intervalima od preporučenih (8-tjedni intervali).
English: for very small dogs 2 - 4.5 kg for small dogs >4.5 - 10 kg for medium-sized dogs >10 - 20 kg for large dogs >20 - 40 kg for very large dogs >40 - 56 kg
Croatian: za vrlo male pse 2 - 4,5 kg za male pse >4,5 - 10 kg za srednje velike pse >10 - 20 kg za velike pse >20 - 40 kg za vrlo velike pse >40 - 56 kg
English: It is efficacious against ticks (Ixodes spp.)
Croatian: Učinkovit je protiv krpelja (Ixodes spp.) i buha (Ctenocephalides spp.) na mačkama.
English: EU/2/13/158/016-017 112.5 mg EU/2/13/158/020-021 250 mg EU/2/13/158/024-025 500 mg EU/2/13/158/028-029 1,000 mg EU/2/13/158/030-031 1,400 mg
Croatian: EU/2/13/158/020-021 250 mg EU/2/13/158/024-025 500 mg EU/2/13/158/028-029 1000 mg EU/2/13/158/030-031 1400 mg
English: No adverse reactions were observed following oral administration to puppies aged 8-9 weeks and weighing 2.0-3.6 kg treated with overdoses of up to 5 times the maximum recommended dose (56 mg, 168 mg and 280 mg fluralaner/kg bodyweight) on three occasions at shorter intervals than recommended (8-week intervals).
Croatian: Nisu se pokazale nikakve nuspojave prilikom peroralne primjene na štencima u starosti 8 do 9 tjedana i težine 2,0-3,6 kg, tretiranih 5 puta većim dozama od maksimalne preporučene doze (56 mg, 168 mg i 280 mg fluralanera/ kg tjelesne težine) u 3 navrata, s kraćim intervalima od preporučenog (8-tjedni intervali).
English: No adverse reactions were observed following topical administration to puppies aged 8-9 weeks and weighing 2.0-3.7 kg treated with overdoses of up to 5 times the maximum recommended dose (56 mg, 168 mg and 280 mg fluralaner/kg bodyweight) on three occasions at shorter intervals than recommended (8-week intervals).
Croatian: Nisu uočene nikakve nuspojave prilikom primjene na koži, na štencima starosti 8 do 9 tjedana i težine 2,0 - 3,7 kg tretiranih 5 puta većim dozama od maksimalne preporučene doze (56 mg, 168 mg i 280 mg fluralanera/kg tjelesne težine) u 3 navrata, s kraćim intervalima od preporučenog (8-tjedni intervali).
English: Dog
Croatian: Pas
English: Mild and transient skin reactions such as erythema or alopecia at the application site were commonly observed in clinical trials (1.2% of treated dogs).
Croatian: Blage i prolazne kožne reakcije kao što su eritem ili gubitak dlake na mjestu aplikacije uočene su često u kliničkim ispitivanjima (1,2 % tretiranih pasa).
English: 1 chewable tablet 2 chewable tablets 4 chewable tablets
Croatian: VELIČINA PAKOVANJA 1 tableta za žvakanje
English: The product should not be administered at intervals shorter than 8 weeks as the safety for shorter intervals has not been tested.
Croatian: Proizvod se ne smije primjenjivati u intervalima kraćim od 8 tjedana zbog nedostatka ispitivanja neškodljivosti.
English: Individual variation in Cmax and t1/2 was observed.
Croatian: Primijećena je individualna varijacija Cmax i t1/2 . Glavni put eliminacije je izlučivanje nepromijenjenog fluralanera u fecesu (~ 90% doze).
English: EU/2/13/158/014 EU/2/13/158/015
Croatian: EU/2/13/158/011 EU/2/13/158/012 EU/2/13/158/013 EU/2/13/158/014 EU/2/13/158/015
English: Each chewable tablet of Bravecto contains:
Croatian: Svaka Bravecto tableta za žvakanje sadrži: Bravecto tablete za žvakanje
English: For dogs above 56 kg body weight, use a combination of two pipettes that most closely matches the body weight.
Croatian: Za pse iznad 56 kg tjelesne težine primjenjivati kombinaciju od 2 tablete koje najviše odgovaraju tjelesnoj težini.
English: for very small dogs (2-4.5 kg) for small dogs (>4.5-10 kg) for medium-sized dogs (>10-20 kg) for large dogs (>20-40 kg) for very large dogs (>40-56 kg)
Croatian: za vrlo male pse (2-4,5 kg) za male pse (>4,5-10 kg) za srednje velike pse (>10-20 kg) za velike pse (>20-40 kg) za vrlo velike pse (>40-56 kg)
English: Safety was demonstrated in kitten aged 11-13 weeks and weighing 1.2-1.5 kg treated with overdoses of up to 5 times the maximum recommended dose on three occasions at shorter intervals than recommended (8-week intervals).
Croatian: Neškodljivost je dokazana kod mačića starosti 11 - 13 tjedana i težine 1,2 - 1,5 kg tretiranih trokratno s 5 x većim dozama od maksimalno preporučene doze i u kraćim intervalima od preporučenih (8tjedni intervali).
English: 0.4 ml 0.89 ml 1.79 ml 3.57 ml 5.0 ml
Croatian: 3,57 ml 5,0 ml
English: During laboratory and clinical field testing, no interactions between Bravecto spot-on solution for cats and routinely used veterinary medicinal products were observed.
Croatian: Tijekom terenskih ispitivanja, nisu primijećene interakcije između Bravecto otopine za nakapavanje za mačke i rutinski korištenih veterinarsko-medicinskih proizvoda.
English: For the treatment of tick and flea infestations in cats.
Croatian: Za liječenje infestacije mačaka krpeljima i buhama.
English: For dogs above 56 kg bodyweight, use a combination of two tablets that most closely matches the bodyweight.
Croatian: Psima iznad 56 kg primjenjuje se kombinacija od 2 tablete koje najviše odgovaraju tjelesnoj težini.
English: For the treatment of tick and flea infestations in dogs.
Croatian: Za liječenje infestacije pasa krpeljima i buhama.
English: 112.5 mg fluralaner 250 mg fluralaner 500 mg fluralaner
Croatian: SASTAV DJELATNIH TVARI 112,5 mg fluralaner 250 mg fluralaner 500 mg fluralaner
English: Safety was demonstrated in puppies aged 8-9 weeks and weighing 2.0-3.6 kg treated with overdoses of up to 5 times the maximum recommended dose on three occasions at shorter intervals than recommended (8-week intervals).
Croatian: Neškodljivost je dokazana u štenadi stare 8 do 9 tjedana i težine 2,0-3,6 kg tretiranih trokratno s 5 x većim dozama od maksimalno preporučene doze i u kraćim intervalima od preporučenih (8-tjedni intervali).
English: Safety was demonstrated in puppies aged 8-9 weeks and weighing 2.0-3.7 kg treated with overdoses of up to 5 times the maximum recommended dose on three occasions at shorter intervals than recommended (8-week intervals).
Croatian: Neškodljivost je dokazana u štenadi stare 8 do 9 tjedana i težine 2,0 - 3,7 kg tretiranih trokratno s 5 x većim dozama od maksimalno preporučene doze i u kraćim intervalima od preporučenih (8-tjedni intervali).
English: During laboratory and clinical field testing, no interactions between Bravecto spot-on solution for dogs and routinely used veterinary medicinal products were observed.
Croatian: Tijekom terenskih ispitivanja, nisu primijećene interakcije između Bravecto otopine za nakapavanje za pse i rutinski korištenih veterinarsko-medicinskih proizvoda.
English: This veterinary medicinal product is a systemic insecticide and acaricide that provides immediate and persistent flea (Ctenocephalides felis) and tick (Ixodes ricinus) killing activity for 12 weeks.
Croatian: Ovaj veterinarsko - medicinski proizvod je sustavni insekticid i akaricid koji trenutno i kontinuirano ubija buhe (Ctenocephalides felis) i krpelje (Ixodes ricinus), tijekom 12 tjedana.
English: EU/2/13/158/018-019 112.5 mg EU/2/13/158/022-023 250 mg EU/2/13/158/026-027 500 mg
Croatian: BROJ(EVI) ODOBRENJA ZA STAVLJANJE U PROMET EU/2/13/158/018-019 112,5 mg EU/2/13/158/022-023 250 mg EU/2/13/158/026-027 500 mg
English: Pharmacotherapeutic group: Ectoparasiticides for systemic use.
Croatian: FARMAKOLOŠKA SVOJSTVA Farmakoterapijska grupa: Ektoparaziticidi za sustavnu upotrebu ATCvet kod: QP53BE02
English: Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
Croatian: Ne primjenjivati kod slučajeva preosjetljivosti na djelatnu tvar ili na bilo koju pomoćnu tvar.
English: Mild and transient skin reactions at the application site, such as erythema and pruritus or alopecia were commonly observed in clinical trials (2.2% of treated cats).
Croatian: Blage i prolazne kožne reakcije na mjestu aplikacije, kao što su eritem, svrbež ili gubitak dlake često su uočene u kliničkim ispitivanjima (2,2 % tretiranih mačaka).
English: Spot-on use.
Croatian: Otopina za nakapavanje.
English: In the absence of available data, this veterinary medicinal product should not be used on puppies less than 8 weeks old and /or dogs weighing less than 2 kg.
Croatian: U nedostatku dostupnih informacija, ovaj veterinarsko medicinski proizvod ne treba upotrebljavati kod štenadi mlađoj od 8 tjedana i/ili psima lakšim od 2 kg.
English: The onset of effect is within 8 hours of attachment for fleas (C. felis) and 12 hours of attachment for ticks (I. ricinus).
Croatian: Do početka učinka dolazi unutar 8 sati nakon prihvaćanja buha (C. felis) i unutar 12 sati nakon prihvaćanja krpelja (I. ricinus).
English: The veterinary medicinal product was well tolerated in Collies with a deficient multidrug-resistanceprotein 1 (MDR1 -/-) following single oral administration at 3 times the recommended dose (168 mg/kg bodyweight).
Croatian: Ovčari pasmine Collie s deficijentnim proteinom (multidrug - resistance - protein 1, MDR1 -/-) nakon jedne peroralne primjene doze 3 puta više od preporučene (168 mg/kg tjelesne težine) dobro su podnijeli veterinarsko - medicinski proizvod.
English: Rotate cap (cap cannot be removed).
Croatian: 2. Okrenite kapicu (kapica se ne može odstraniti) 3. Primijenite na kožu.
English: Fluralaner was well tolerated in Collies with a deficient multidrug-resistance-protein 1 (MDR1 -/-) following single oral administration at 3 times the maximum recommended dose (168 mg/kg bodyweight).
Croatian: Ovčari pasmine Collie s deficijentom proteina (multidrug - resistance - protein 1, MDR1 -/-) nakon primjene jedne peroralne doze, 3 x veće od preporučene (168 mg/kg tjelesne težine) dobro su podnijeli veterinarsko - medicinski proizvod.
English: This veterinary medicinal product is a systemic insecticide and acaricide that provides: - immediate and persistent flea (Ctenocephalides felis and Ctenocephalides canis) killing activity for 12 weeks, and - immediate and persistent tick (Ixodes ricinus, Rhipicephalus sanguineus and Dermacentor reticulatus) killing activity for 12 weeks.
Croatian: Ovaj veterinarsko-medicinski proizvod je sustavni insekticid i akaricid koji omogućuje: - trenutno i kontinuirano ubijanje buha (Ctenocephalides felis i Ctenocephalides canis) tijekom 12 tjedana, - trenutno i kontinuirano ubijanje krpelja tijekom 12 tjedana za Ixodes ricinus, Dermacentor reticulatus i Rhipicephalus sanguineus.
English: This veterinary medicinal product is a systemic insecticide and acaricide that provides: - immediate and persistent flea (Ctenocephalides felis and C. canis) killing activity for 12 weeks, - immediate and persistent tick (Ixodes ricinus, Rhipicephalus sanguineus and Dermacentor reticulatus) killing activity for 12 weeks.
Croatian: Ovaj veterinarsko - medicinski proizvod je sustavni insekticid i akaricid koji: - trenutno i kontinuirano ubija buhe (Ctenocephalides felis), tijekom 12 tjedana, - trenutno i kontinuirano ubija krpelje tijekom 12 tjedana (Ixodes ricinus, Rhipicephalus sanguineus, Dermacentor reticulatus).